JP2011522553A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011522553A5 JP2011522553A5 JP2011512983A JP2011512983A JP2011522553A5 JP 2011522553 A5 JP2011522553 A5 JP 2011522553A5 JP 2011512983 A JP2011512983 A JP 2011512983A JP 2011512983 A JP2011512983 A JP 2011512983A JP 2011522553 A5 JP2011522553 A5 JP 2011522553A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- growth factor
- interleukin
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 claims 6
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 claims 6
- 102000004889 Interleukin-6 Human genes 0.000 claims 6
- 108090001005 Interleukin-6 Proteins 0.000 claims 6
- 102000004890 Interleukin-8 Human genes 0.000 claims 6
- 108090001007 Interleukin-8 Proteins 0.000 claims 6
- 229940100601 interleukin-6 Drugs 0.000 claims 6
- 229940096397 interleukin-8 Drugs 0.000 claims 6
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 claims 6
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 4
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 4
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 4
- 238000012258 culturing Methods 0.000 claims 4
- 102000049853 macrophage stimulating protein Human genes 0.000 claims 4
- 108010053292 macrophage stimulating protein Proteins 0.000 claims 4
- 239000003636 conditioned culture medium Substances 0.000 claims 3
- 239000001963 growth medium Substances 0.000 claims 3
- 210000003494 hepatocyte Anatomy 0.000 claims 3
- 210000004185 liver Anatomy 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims 2
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 claims 2
- 239000006143 cell culture medium Substances 0.000 claims 2
- 210000003237 epithelioid cell Anatomy 0.000 claims 2
- 229940116978 human epidermal growth factor Drugs 0.000 claims 2
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 102000008100 Human Serum Albumin Human genes 0.000 claims 1
- 108091006905 Human Serum Albumin Proteins 0.000 claims 1
- 206010053159 Organ failure Diseases 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000002577 cryoprotective agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 230000008816 organ damage Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 238000010257 thawing Methods 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08010651 | 2008-06-11 | ||
| EP08010651.1 | 2008-06-11 | ||
| PCT/EP2009/057232 WO2009150199A1 (en) | 2008-06-11 | 2009-06-11 | Conditioned medium of liver progenitor cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011522553A JP2011522553A (ja) | 2011-08-04 |
| JP2011522553A5 true JP2011522553A5 (enExample) | 2012-07-12 |
| JP5632833B2 JP5632833B2 (ja) | 2014-11-26 |
Family
ID=40905279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011512983A Active JP5632833B2 (ja) | 2008-06-11 | 2009-06-11 | 肝臓前駆細胞の馴化培地 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10456425B2 (enExample) |
| EP (1) | EP2296672B1 (enExample) |
| JP (1) | JP5632833B2 (enExample) |
| CN (2) | CN102119031B (enExample) |
| BR (1) | BRPI0909866B1 (enExample) |
| CA (1) | CA2727392C (enExample) |
| DK (1) | DK2296672T3 (enExample) |
| ES (1) | ES2556630T3 (enExample) |
| HU (1) | HUE028676T2 (enExample) |
| PL (1) | PL2296672T3 (enExample) |
| PT (1) | PT2296672E (enExample) |
| WO (1) | WO2009150199A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2333047A1 (en) * | 2009-12-09 | 2011-06-15 | Fresenius Medical Care Deutschland GmbH | Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease |
| US8603470B1 (en) * | 2012-08-07 | 2013-12-10 | National Cheng Kung University | Use of IL-20 antagonists for treating liver diseases |
| DK3016665T3 (da) | 2013-07-05 | 2019-11-25 | Univ Catholique Louvain | Konditioneret medium fra humane voksne leverstamceller og dets anvendelse i behandlingen af leverlidelser |
| BR112016004911A2 (pt) | 2013-09-05 | 2017-09-05 | Inis Biotech Llc | Proteína secretada, acídica e rica em cisteína, um novo alvo para o tratamento e prevenção de insuficiência aguda do fígado |
| RU2644650C2 (ru) * | 2014-12-01 | 2018-02-13 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток и способ его получения |
| CN104818245B (zh) * | 2015-05-29 | 2020-02-04 | 广州赛莱拉干细胞科技股份有限公司 | 一种肝脏干细胞的培养基及培养方法 |
| AU2017217688B2 (en) | 2016-02-10 | 2023-01-19 | Wake Forest University Health Sciences | Model system of liver fibrosis and method of making and using the same |
| RU2708329C2 (ru) | 2016-05-31 | 2019-12-05 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток, композиции и способы применения |
| US20200087390A1 (en) | 2016-12-21 | 2020-03-19 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| EP3801028A4 (en) | 2018-05-30 | 2022-04-13 | Direct Biologics LLC | A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use |
| CN109628377A (zh) * | 2019-01-02 | 2019-04-16 | 贵州省人民医院 | 一种小鼠原代肝细胞灌注式分离及离体培养方法 |
| CN111607556B (zh) | 2019-01-25 | 2022-06-07 | 中国科学院广州生物医药与健康研究院 | 一种培养扩增人肝祖细胞的培养基及其应用 |
| EP3920946A4 (en) | 2019-02-07 | 2022-11-09 | Direct Biologics LLC | METHOD FOR TREATING OSTEOARTHRITIS USING A COMBINATION OF EXOSOMES OF MESENCHYMATE STEM CELLS, SYNOVIAL MESENCHYMATE STEM CELLS AND SCAFFOLDS |
| CN113939585A (zh) * | 2019-04-30 | 2022-01-14 | 普罗米瑟拉疗法公司 | 人同种异体肝源性祖细胞的制备 |
| CN111394391B (zh) * | 2019-07-11 | 2022-12-06 | 上海赛立维生物科技有限公司 | 肝祖细胞样细胞库的构建方法及其制备的细胞株与应用 |
| CA3146433A1 (en) | 2019-07-18 | 2021-01-21 | Direct Biologics Llc | Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use |
| KR20230004709A (ko) | 2020-04-22 | 2023-01-06 | 다이렉트 바이오로직스 엘엘씨 | 감염성 질환과 연관된 염증성 병태를 치료하기 위한 방법 및 조성물 |
| WO2025226276A1 (en) | 2024-04-25 | 2025-10-30 | Direct Biologics, Llc | Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH093099A (ja) * | 1995-06-20 | 1997-01-07 | Toyobo Co Ltd | マクロファージ刺激蛋白質改変体およびその製造法 |
| US6475490B1 (en) * | 1998-10-19 | 2002-11-05 | Fordham University | Compositions and methods for promoting tissue repair using heat shock proteins |
| US6372494B1 (en) * | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
| US6719969B1 (en) * | 1999-08-09 | 2004-04-13 | The Regents Of The University Of Michigan | Treatment of liver disease and injury with CXC chemokines |
| CA2290240C (en) * | 1999-11-24 | 2008-03-11 | Stergios Stergiopoulos | High resolution 3d ultrasound imaging system deploying a multi-dimensional array of sensors and method for multi-dimensional beamforming sensor signals |
| US7547674B2 (en) * | 2001-06-06 | 2009-06-16 | New York Medical College | Methods and compositions for the repair and/or regeneration of damaged myocardium |
| US6916770B2 (en) | 2001-04-27 | 2005-07-12 | Polyone Corporation | Multi-functional color concentrate compositions |
| CA2452865A1 (en) * | 2001-06-07 | 2002-12-12 | Skinmedica, Inc. | Conditioned cell culture media and uses thereof |
| WO2003033697A1 (en) * | 2001-10-18 | 2003-04-24 | Ixion Biotechnology, Inc. | Conversion of liver stem and progenitor cells to pancreatic functional cells |
| WO2006126219A1 (en) | 2005-05-26 | 2006-11-30 | Fresenius Medical Care Deutschland G.M.B.H. | Liver progenitor cells |
| JP2009527475A (ja) * | 2006-02-16 | 2009-07-30 | バーンハム インスティトゥート フォー メディカル リサーチ | ヒト胚性幹細胞又は他の前駆細胞により馴化された培地、及びその使用 |
| CN103893211A (zh) * | 2006-03-07 | 2014-07-02 | 吉塔·什罗夫 | 包含人胚胎干细胞和其衍生物的组合物、其使用方法和制备方法 |
| FR2912916B1 (fr) * | 2007-02-26 | 2009-05-22 | Oreal | Composition cosmetique ou dermatologique comprenant un milieu de culture cellulaire |
-
2009
- 2009-06-11 BR BRPI0909866-6A patent/BRPI0909866B1/pt active IP Right Grant
- 2009-06-11 CN CN200980131229.6A patent/CN102119031B/zh active Active
- 2009-06-11 ES ES09761761.7T patent/ES2556630T3/es active Active
- 2009-06-11 PL PL09761761T patent/PL2296672T3/pl unknown
- 2009-06-11 EP EP09761761.7A patent/EP2296672B1/en active Active
- 2009-06-11 DK DK09761761.7T patent/DK2296672T3/en active
- 2009-06-11 WO PCT/EP2009/057232 patent/WO2009150199A1/en not_active Ceased
- 2009-06-11 US US12/737,143 patent/US10456425B2/en active Active
- 2009-06-11 CN CN201310348088.1A patent/CN103800895B/zh active Active
- 2009-06-11 CA CA2727392A patent/CA2727392C/en active Active
- 2009-06-11 HU HUE09761761A patent/HUE028676T2/en unknown
- 2009-06-11 JP JP2011512983A patent/JP5632833B2/ja active Active
- 2009-06-11 PT PT97617617T patent/PT2296672E/pt unknown
-
2017
- 2017-01-23 US US15/412,142 patent/US10357519B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2928670T3 (es) | Formulación que contiene virus y utilización de la misma | |
| ES2583371T3 (es) | Composiciones, métodos, y dispositivos para tratar enfermedades hepáticas | |
| US20210008106A1 (en) | Mitochondrial treatment of organs for transplantation | |
| Johansson et al. | Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate | |
| Liu et al. | Study on therapeutic action of bone marrow derived mesenchymal stem cell combined with vitamin E against acute kidney injury in rats | |
| JP2023017017A (ja) | 上皮間葉転換を予防または最小限にする方法及び組成物 | |
| CN110177872A (zh) | 间充质干细胞和药物组合物 | |
| JP2023537204A (ja) | 間葉系ストローマ細胞由来の細胞外小胞(ev)および前記evを得るための方法 | |
| CN107114356A (zh) | 一种胎盘及脐带细胞保护液 | |
| JP2023520233A5 (enExample) | ||
| ES2966620T3 (es) | Preparación de células progenitoras hepáticas alogénicas humanas | |
| CN105377275A (zh) | 用于静脉给药的干细胞组合物 | |
| TW202100170A (zh) | 用於治療慢性肝衰竭之急性發作的成人肝先驅細胞 | |
| TW202035682A (zh) | 表現hla-g之肝先驅細胞及取得包含該等細胞之此等細胞組成物之方法與其用途 | |
| EP3947645A1 (en) | Adult liver progenitor cells for treating non-alcoholic fatty liver disease | |
| WO2023077160A1 (en) | Methods of treating diseases associated with cellular-energy deficiency or mitochondrial dysfunction by locoregional delivery of extracellular vesicles that have a cargo with an enhanced bioenergetic profile | |
| EP3923965A1 (en) | Methods and compositions for treating viral infections and sequelae thereof | |
| CN107980767B (zh) | 一种长期保存过表达ang-1的epc的保存液 | |
| Zhou et al. | ROS-responsive diselenide exosomes restores mitophagy to resolve sterile inflammation in liver IRI | |
| CN105532646A (zh) | 肝细胞保存液及其制备方法和应用 | |
| EP2175718B1 (en) | Body fluid expanders comprising n-substituted aminosulfonic acid buffers | |
| CN106474157B (zh) | 一种肝干细胞注射液及其制备方法 | |
| CN103301118A (zh) | 注射用精氨酸布洛芬组合物 | |
| US20220049225A1 (en) | Cell composition comprising liver progenitor cells expressing hla-e | |
| CN116510013A (zh) | 一种靶向血管治疗肝纤维化的药物组合物及应用方法 |